BIO

Born in Kansas and raised in Nebraska, Dr. Wohlgemuth attended the University of Nebraska-Lincoln, where he majored in Biochemistry and was a undergraduate research assistant in the laboratory of Dr. James L. Van Etten studying viruses of unicellular green algae known as Chloroviruses. As part of collaboration at the Johns Hopkins University School of Medicine, upon graduation, Dr. Wohlgemuth was hired as a technician in the labs of Drs. Robert Yolken and Lorraine Jones-Brando in the Stanley Division of Developmental Neurovirology at the Johns Hopkins School of Medicine. He then moved across to street to study for his Ph.D. in the laboratory of Dr. Andrew Pekosz at the Johns Hopkins School of Public Health where he studied the cellular and molecular biology of influenza A virus attenuation and protein mis-localization. Subsequently, Dr. Wohlgemuth pursued postdoctoral training in the laboratory of Dr. Stacey Schultz-Cherry at St. Jude Children's Research Hospital. There he studied the pathogenesis of influenza viruses in obese hosts and developed novel systems for studying complex interactions between primary respiratory cell types. During the COVID-19 pandemic, he help develop a series of neutralizing antibodies at St. Jude for use in clinical trials.